Presentations 13 Apr 2023 Using Technology to collect DATA that makes sense for HTA Vidya Breeveld-Dwarkasing
Real World Evidence 19 Oct 2022 Real World Evidence, an opportunity to prove value of highly individualized medicines in real life clinical practice, but limitations need to be addressed. Real-World Evidence generation becoming increasingly important but also very complicated Based on the EMA’s horizon scanning activities, it has been… Vidya Breeveld-Dwarkasing
Presentations 05 Jul 2022 HTA and decision making in the reimbursement of medicines Vidya Breeveld-Dwarkasing
Market Access peering through a window to the world -Image Credit: NASA 10 Jun 2022 Changing the Pathway for successful Biopharma Launches Vidya Breeveld-Dwarkasing
Presentations 11 May 2022 How AI And Machine Learning Can Improve Patient Access To Orphan Drugs Vidya Breeveld-Dwarkasing
Market Access 11 May 2022 How Market Access Challenges Lead To Solidarity Conflicts Vidya Breeveld-Dwarkasing
